Press Room Contact Us Career Opportunities
         
 
 

Lazard Capital Markets is a growth-oriented full service broker-dealer with a unique position in today's capital markets. 

Our Institutional clients value our focused, action-oriented proprietary research, which is based on deep domain expertise in the Healthcare, Consumer, Energy, Technology and Transportation sectors. 

Our Sales and Trading professionals have long-standing relationships with over 600 institutional accounts, and, with an average of 15 years of experience, have an intimate knowledge of our clients' investment objectives. Finally, our relationship with Lazard, an international investment bank, which operates in 39 cities across 21 countries, provides us with unparalleled global connections. 

The distinctive combination of our experience, focus, global reach, and thought leadership provides clients with an unparalleled resource: Lazard Capital Markets.


                                                                                                                                                                   
 
AEO: Higher denim AURs could boost Feb. comps by 6%; BUY        Lazard Capital Markets Daily Monday, February 08, 2010        LTD: More red at VS should drive more Feb. comp; BUY        GFF: Detailed review of 1Q results increases our conviction; BUY        WXS: Expect upside again in 4Q09 on higher fuel prices; BUY        CVLT: As data grows, so does CommVault; company is a top pick for 2010; BUY        LCM SoftWeek: The week in software        LCM Media and Technology: Weekly calendar update        Takeaways from Roche analyst meeting for AMLN, ALKS, HALO, ITMN, and VRUS        LCM Movie Projector: Weekend fell, but still beat LCMe        Lazard Capital Markets Daily Monday, February 08, 2010        Lazard Capital Markets Daily Monday, February 08, 2010        AEO: Higher denim AURs could boost Feb. comps by 6%; BUY        Weekly Valuation/Financial Ratio Comparisons        CVS: First look at Q4 results, waiting for 2010 guidance; BUY        Flu activity plateaus        LCM Voices from Asia, China series – takeaways from management conference call with Gome        Corrected: Takeaways from Roche analyst meeting for AMLN, ALKS, HALO, ITMN, and VRUS        STJ: Analyst day mixed; pipeline looks promising; leverage likely; concerns on pricing and aggressive goals linger; HOLD        ENER, ESLR, JASO earnings preview       
 
      Terms and Conditions of Use   Member FINRA / SIPC